. Several adhesion factors that mediate the binding of EHEC to intestinal cells have been described, but the receptors involved in their recognition are not fully characterized. Extracellular matrix (ECM) proteins might act as receptors involved in the recognition of enteric pathogens, including EHEC. In this study, we sought to characterize the binding of EHEC O157:H7 to ECM proteins commonly present in the intestine. We found that EHEC prototype strains as well as other clinical isolates adhered more abundantly to surfaces coated with fibronectin, laminin, and collagen IV. Further characterization of this phenotype, by using antiserum raised against the LpfA1 putative major fimbrial subunit and by addition of mannose, showed that a reduced binding of EHEC to ECM proteins was observed in a long polar fimbria (lpf) mutant. We also found that the two regulators, H-NS and Ler, had an effect in EHEC Lpf-mediated binding to ECM, supporting the roles of these tightly regulated fimbriae as adherence factors. Purified Lpf major subunit bound to all of the ECM proteins tested. Finally, increased bacterial adherence was observed when T84 cells, preincubated with ECM proteins, were infected with EHEC. Taken together, these findings suggest that the interaction of Lpf and ECM proteins contributes to the EHEC colonization of the gastrointestinal tract.
Enterohemorrhagic Escherichia coli (EHEC) strains are emerging pathogens distributed worldwide. EHEC strains have been associated with food-transmitted diseases, and they are the etiologic agent of acute diarrhea, bloody diarrhea, and in some cases, hemolytic uremic syndrome (HUS) (23) . E. coli O157:H7 is the serotype most frequently associated with sporadic cases and large outbreaks (4) . Adherence to intestinal cells is a critical step in EHEC pathogenesis. This process involves the recognition of receptor(s), located at the surface of the target cells, by adhesion factors expressed on the bacterial surface (23, 35) . To date, the intimin protein and the long polar fimbriae (Lpf) are the only two factors of EHEC that have been demonstrated to play a role in persistence and the colonization of the intestine (5, 9, 12, 17, 29, 33) . Further, the presence of intimin-negative EHEC strains that can cause severe disease in humans, including HUS (22) , have led to the discovery of other putative adhesins (10, 15, 16, 20, 21, 24-26, 30, 31, 37, 39) .
EHEC O157:H7 contains two nonidentical lpf loci with homology to loci of the Lpf of Salmonella enterica serovar Typhimurium (30, 31) . Both Lpf proteins have been associated with increased adherence to tissue-cultured cells, and mutations in one or both of the lpf loci resulted in diminished colonization abilities in animal models (swine, lamb, and sheep) (12, 33) and displayed altered human intestinal tissue tropism (9) . The lpf1 locus is highly regulated by environmental signals and by the bacterial transcriptional regulators H-NS and Ler (short for locus of enterocyte effacement-encoded regulator) (32, 34) . Although the importance of Lpf as an EHEC adhesion factor mediating binding to epithelial cells has been demonstrated, the receptor(s) involved in their recognition are unknown. Considering that the ability to adhere to ECM proteins has been shown to be essential for the virulence of several pathogens (38) , these proteins appear to be promising candidates for interaction with EHEC adhesins.
The ECM proteins comprise a diverse group that function as a barrier and support for epithelial cells and that are responsible for the development, growth, and maintenance of mammalian tissues (1) . The composition of ECM differs in various organs, but fibronectin, collagen types I to XV, and laminin are common constituents (6) . ECM proteins are commonly recognized by bacterial adhesins and have been shown to act as a substrate for bacterial adherence to eukaryotic cells (8, 11, 13, 14, 38) . Although ECM proteins generally are localized to the basement membrane, interaction with enteric bacterial pathogens can occur during inflammation or the opening of tight junctions (36) . Therefore, binding to ECM proteins may facilitate colonization, invasion, and/or signaling by intestinal pathogens.
In the current study, we investigated whether EHEC prototype strains and other O157:H7 clinical isolates are able to bind ECM proteins. We observed the binding of EHEC to the most common ECM proteins found in the intestine. Our data also indicated that Lpf are recognized by ECM proteins, and that this binding eventually participates in the EHEC adherence to the intestinal cells.
MATERIALS AND METHODS
Bacterial strains and reagents. Bacterial strains used in this study are listed in Table 1 . Clinical EHEC O157:H7 isolates were obtained from the Programa de Microbiología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile. All bacteria were grown in static conditions overnight in DMEM-0.5% glucose (DMEM-HG) or Luria-Bertani (LB) broth. Fibronectin (from human plasma) and proteolytic fragments of fibronectin (30, 45 , and 70 kDa), laminin (Engelbreth-Holm-Swarm murine sarcoma), collagen IV (human placenta), and bovine serum albumin (BSA) were purchased from Sigma (St. Louis, MO). A 120-kDa proteolytic fragment of fibronectin was purchased from Millipore (Billerica, MA).
rLpfA1 purification. Recombinant LpfA1 (rLpfA1) was expressed using BL21(DE3) pLysS cells possessing a copy of lpfA1 without the putative signal sequence cloned into pET-28a(ϩ) (EMD, Darmstadt, Germany). Prewarmed LB was inoculated 1:100 with an overnight culture of E. coli BL21(DE3) pLysSlpfA1 plus 50 g/ml kanamycin and 30 g/ml chloramphenicol. The batch culture was incubated at 37°C with shaking and induced with 1 mM isopropyl-␤-Dthiogalactopyranoside (IPTG) for 4 h upon reaching mid-log phase. After centrifugation, the cell pellet was sonicated in lysis buffer (50 mM NaH 2 PO 4 , 0.5 M NaCl, 10 mM imidazole, pH 7.8) supplemented with 1 mg/ml lysozyme and protease inhibitor cocktail (Complete, Mini, EDTA-free; Roche, Indianapolis, IN). Nickel-nitrilotriacetic acid (Ni-NTA) agarose beads (Qiagen, Valencia, CA) were washed three times (with 50 mM NaH 2 PO 4 , 0.5 M NaCl, 40 mM imidazole, 1% Triton X-100, pH 7.8) before the addition of the cleared lysate. After 1 h of incubation at 4°C, the beads were washed three times before application to a Poly-Prep chromatography column (Bio-Rad, Hercules, CA). The beads were washed again, and His 6 -tagged LpfA1 was eluted from the beads (50 mM NaH 2 PO 4 , 0.5 M NaCl, 200 mM imidazole, pH 7.8).
Preparation of rLpfA1 antiserum. An anti-LpfA1 rat immune serum was obtained from Harlan Laboratories, Inc., using the rLpfA1 protein excised from a polyacrylamide gel. The specificity of the antibodies was determined by Western blot analyses.
SDS-PAGE and Western blot analyses. EHEC strain EDL933 and strain AGT204 (lpf1 mutant) were grown in DMEM-HG, and 1 ml of bacterial suspension containing ϳ1 ϫ 10 8 bacteria was centrifuged. The pellet was resuspended in protein loading buffer and boiled for 10 min. Protein electrophoresis was performed in 10% SDS-polyacrylamide gels, and the proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Millipore). Membranes were incubated with blocking buffer (5% [wt/vol] nonfat milk in phosphatebuffered saline [PBS] ) and then with anti-LpfA1 or anti-GroEL (Sigma) antibodies. The activity of a horseradish peroxidase (HRP)-labeled secondary antibody was visualized by adding TMB substrate (KPL, Gaithersburg, MD) directly to the membrane.
ELISA. Binding to ECM proteins was evaluated as previously described (8) . Briefly, microtiter plates (Thermo Labsystems, Franklin, MA) were coated with a solution of 10 g/ml of protein per well in 100 mM Tris-HCl (pH 8.0) buffer overnight at 4°C. Unbound protein was removed and blocked with 1% BSA for 1 h at room temperature. A final volume of 200 l of DMEM-HG medium containing ϳ1 ϫ 10 7 bacteria was added to the wells and incubated for 4 h at 37°C. A rabbit anti-O157 serum (Denka Seiken Co., Ltd., Tokyo, Japan), diluted 1:1,000, was added to the wells and incubated for 90 min at room temperature. Anti-rabbit HRP (KPL, Gaithersburg, MD) and peroxidase activity associated with each well were detected by the addition of TMB substrate solution (KPL). Optical densities at 450 nm (OD 450 ) were read with a 96-well plate reader. To analyze binding data, the background absorbance from wells in which bacteria were not added was subtracted from the absorbance in test wells. For rLpfA1 binding, 10 g/ml of rLpfA1 was added to ECM protein-coated wells and incubated for 4 h at room temperature. An anti-LpfA1 serum raised in rats (diluted 1:2,000) was used to detect the bound protein. The deglycosylation of fibronectin, laminin, and type IV collagen was carried out by the digestion of 10 g of each ECM protein at 37°C for 4 h with 1,000 U of N-glycosidase F (PNGase F; New England BioLabs, Hitchin, United Kingdom) or 50 mM sodium meta-periodate (Merck, Darmstadt, Germany). In parallel, ECM proteins were treated with buffer alone. Treated and control ECM proteins were used to coat microtiter plates to evaluate EHEC EDL933 binding by enzyme-linked immunosorbent assay (ELISA).
Quantification of bacterial binding. Wells of 24-well plates were coated with a solution of 10 g/ml of test protein per well in 100 mM Tris-HCl (pH 8.0) buffer and allowed to bind overnight at 4°C. Unbound protein was removed and blocked with 1% BSA for 1 h at room temperature. One milliliter of DMEM-HG containing ϳ1 ϫ 10 8 bacteria was added to each well, and the plate was incubated at 37°C for 4 h. After washing the wells with PBS, the bacterial cells that adhered to wells were collected by scraping into distilled water; serial dilutions were plated onto LB agar plates. The number of adherent bacteria was determined by counting individual colonies. To evaluate the role of mannose, bacteria were incubated in DMEM-HG with 1% methyl-␣-D-mannopyranoside (D-mannose; Sigma).
Pull-down analysis. Wild-type EHEC strain EDL933 was grown in DMEM-0.5% glucose, and approximately 1 ϫ 10 8 bacteria were collected by centrifugation and washed twice in 0.5 ml of PBS. Nonspecific binding sites were blocked in 0.5 ml of 3% BSA in PBS for 1 h at room temperature. The cells were collected again by centrifugation, and cells were resuspended in a solution of 10 g/ml of fibronectin and incubated for 3 h at room temperature on a tabletop rotator. Unbound fibronectin was removed by washing the cells with PBS. Cell-associated fibronectin was detected by Western blot analysis using a rabbit anti-fibronectin antibody (Sigma).
Light microscopy. Labtek eight-well chamber slides (Becton Dickinson) were coated with ECM proteins as described above. After being washed with PBS, 1 ml of DMEM-0.5% glucose containing ϳ1 ϫ 10 8 bacteria was added, and the plate was incubated at 37°C for 4 h. Samples were fixed with ethanol, stained with crystal violet, and visualized by microscopy.
T84 adherence assays. Adherence assays were performed with T84 as previously described (8) . Prior to bacteria inoculation, cell monolayers were incubated with DMEM-F12 medium plus D-mannose for 30 min and 5 g/ml of each ECM protein separately. Medium was aspirated, and 100 l containing ϳ1 ϫ 10 8 CFU/ml bacteria was added to the monolayer. Plates were incubated at 37°C in 5% CO 2 for 4 h and washed with PBS. Cells were lysed with a solution of 0.1% (vol/vol) Triton X-100-PBS, and serial dilutions of the lysates were plated on LB agar. The number of adherent bacteria was determined by counting the resulting colonies in duplicate.
Statistical analysis. Statistical significance between the individual groups was analyzed using the unpaired Student's t test with a threshold of P Ͻ 0.05. Values are expressed as the means Ϯ standard errors of the means from three experiments.
RESULTS
EHEC O157:H7 binds to ECM proteins. We examined the ability of EHEC EDL933 to adhere to the ECM proteins fibronectin, proteolytic fragments of fibronectin, laminin, and collagen IV. As a negative control, we employed bovine serum albumin (BSA). ELISAs using a commercial antiserum against the bacterial O antigen (O157) showed that all of the ECM proteins tested increased the binding of EHEC EDL933 compared to that of the BSA control (Fig. 1A) . We also utilized a pull-down method to determine whether bacteria retain fibronectin (8) . Wild-type EHEC strain EDL933 was incubated with fibronectin, washed extensively, and pelleted by centrifugation. The lysis of the bacterial cells and subsequent Western blot analyses revealed that wild-type bacteria bound fibronectin (Fig. 1B) . These observations also were confirmed by visualizing fixed samples under the microscope (Fig. 1C) . The binding of EHEC EDL933 to serial dilutions of ECM proteins also was evaluated and demonstrated a dose-dependent binding of strain EDL933 to all of the ECM proteins tested (Fig. 1D ). In the converse experiment, the binding of serially diluted EHEC EDL933 to all of the individually tested ECM proteins showed saturation binding kinetics ( Fig. 2A) . Similar results were obtained with a second prototype EHEC, strain 86-24 (data not shown). To evaluate whether the binding of EHEC to ECM proteins occurs for strains besides a particular reference strain, we tested 10 clinical isolates of EHEC O157:H7.
Compared to the binding of EHEC EDL933, no differences in the binding of the 10 clinical strains to fibronectin (Fig. 1E) , laminin, and collagen IV were found (data not shown). Be- (8, 27) , we addressed the possible involvement of glycans in the interaction of EHEC with the ECM proteins. Binding to fibronectin and collagen IV was reduced after periodate oxidation (data not shown) and PNGase treatment (Fig. 1F) , indicating that N-linked glycoprotein is involved in the adherence of these ECM proteins to EHEC. No difference in the binding to laminin was observed after periodate or PNGase treatment, suggesting that its glycoproteins are not involved in the interaction with EHEC. Lpf fimbriae are required for EHEC binding to ECM proteins. Since it has been reported previously that mannose binds to type 1-related fimbriae, competing with the receptor and reducing their adherence properties, we next determined whether mannose had an effect on the binding of EHEC to ECM proteins. Interestingly, we found that the binding to the ECM proteins tested was significantly reduced when this monosaccharide was present during the binding assay (Table   2 ). We next examined the participation of the Lpf fimbriae (which share homology to type 1 fimbriae) in EHEC binding to ECM proteins. We found that the binding of AGT204 (lpfA1 mutant) to all of the ECM proteins tested was significantly reduced compared to that of the parental EHEC strain (Fig.  2A) . The complementation of AGT204 with pLPF100 (30) restored binding to ECM proteins similar to wild-type levels
FIG. 2. Involvement of Lpf fimbriae in EHEC binding to ECM proteins. (A) Serial dilutions of EHEC wild-type strain EDL933 (filled symbols)
and its isogenic mutant AGT204 (open symbols) were added separately to plates coated with 10 g/ml fibronectin (squares), laminin (circles), and type IV collagen (triangles), and the binding was detected by ELISA using anti-O157 antibodies * , P Ͻ 0.01 compared to results with AGT204.
(B) Wild-type EHEC strain EDL933, strain AGT204 (lpf1 mutant), and AGT204 transformed with pLPF100 were added separately to 24-well plates coated with 25 g/ml of fibronectin, laminin, or type IV collagen, and bound bacteria were determined by plating. * , P Ͻ 0.01 compared to results with AGT204. (C) Whole-cell lysates from EHEC strains EDL933 and AGT204 (lpf1 mutant) were analyzed by Western blotting using anti-LpfA1 (ϳ25 kDa) and anti-GroEL (ϳ60 kDa; loading control). (D) EHEC strains AGT204 and EDL933 (with and without preincubation with anti-LpfA1 sera) were added separately to plates coated with 10 g/ml of each ECM protein, and the binding was detected by ELISA using anti-O157 antibodies. The bars represent the means from three experiments, with the error bars indicating the standard deviations. * , P Ͻ 0.01 compared to results with EDL933. (Fig. 2B) . We have demonstrated previously (30) , and now here, that anti-LpfA sera recognized and blocked the LpfA1 protein present in the EHEC EDL 933 strain but not that in the AGT204 strain (Fig. 2C ). In addition, the adherence of a nonfimbriated E. coli strain, ORN172, carrying the pLPF100 plasmid (containing the lpf1 operon), significantly increased the adherence to all the ECM proteins tested compared to that of the ORN172 strain alone (data not shown). Previous studies showed that lpf1 expression is regulated by H-NS and Ler proteins. The H-NS protein binds to the regulatory sequence of lpf1 and silences transcription, while Ler "antisilences" the action of H-NS by binding to the regulatory region of lpf1 (32, 34) . To test whether H-NS and Ler regulation influence EHEC Lpf1-mediated binding to ECM proteins, we assayed the adherence of the following EHEC strains: hns mutant (strain AC425), ler mutant (CB49), lpfA1 mutant (AGT204), hns ler double mutant (SDP01), hns lpfA1 double mutant (TMS002), and hns ler lpfA1 triple mutant (TMS003). Compared to parental EHEC strain EDL933, reduced binding to fibronectin (Table 3) as well as laminin and collagen IV (data not shown) was observed with all mutants strains tested, but the binding was reduced to different levels. The level of binding observed for strain AC425 was higher than that for AGT204, CB49, TMS002, and TMS003 strains but was similar to that of the SDP01 strain. These data confirm the role of H-NS as a negative regulator of lpf1 expression and the participation of these tightly regulated fimbriae in the binding to ECM proteins.
Recombinant LpfA1 subunit binds to ECM proteins. To demonstrate the direct binding of the Lpf fimbriae to ECM proteins, we purified the putative Lpf major subunit, LpfA1 protein. SDS-PAGE analysis revealed that rLpfA copurified with an ϳ18-kDa protein, and further analyses showed that this protein corresponded to IbpA protein (data not shown). IbpA is a heat shock chaperone protein involved in the refolding of denatured proteins (3), including rLpfA. The recombinant protein then was used to raise antibodies in rats. We used this rat anti-LpfA serum to evaluate whether the binding of wild-type strain EDL933 to ECM proteins can be blocked. The preincubation of bacterial suspension with anti-LpfA1 serum significantly reduced the binding of EDL933 to ECM proteins at levels similar to those observed with the AGT204 strain (Fig.  2D) . Also, we evaluated the binding of the purified rLpfA1 protein to 96-well plates coated with individual ECM proteins. Binding to fibronectin, laminin, and type IV collagen was significantly greater than that to BSA (Fig. 3) . Taken together, these observations supported the involvement of Lpf major subunit in binding to the most common ECM proteins found in the intestine.
Binding to ECM proteins facilitates EHEC adherence to intestinal cells. Previous reports indicated that ECM proteins promote the adherence of enteric pathogens to intestinal cultured cells (8, 18 ). Therefore, we tested whether ECM proteins would be able to increase the number of EHEC bacteria adhering to confluent T84 monolayers. We incubated T84 cells separately with 5 g/ml of fibronectin, laminin, collagen IV, and BSA for 30 min prior to EHEC EDL933 infection. Figure  4 illustrates a significant increase in the number of bacteria adhered to cells incubated with ECM protein compared to that for cells incubated only with BSA. 
DISCUSSION
A key aspect of EHEC pathogenesis is the ability of the bacteria to adhere and colonize the human intestine. The existence of EHEC strains that lack intimin but that can still be pathogenic suggested the existence of additional adhesion factors involved in EHEC binding to epithelial cells. After the description of intimin, several adherence factors have been identified in EHEC (2, 7, 19-21, 26, 30, 31, 39) . Although these adhesion factors have been implicated in EHEC binding to epithelial cells, the receptors involved in its recognition are poorly characterized or unknown. In this study, we showed that EHEC O157:H7 prototype strains EDL933 and 86-24 have the ability to bind to the major intestinal ECM proteins, such as fibronectin, laminin, and collagen IV (Fig. 1) . Considering the role of fibronectin in bacterial adherence to cells (11), we tested the binding of EHEC to purified proteolytic fragments of fibronectin to associate the binding to a specific protein region. We found that EHEC EDL933 binds to 30-, 45-, 70-, and 120-kDa proteolytic fragments, suggesting that these bacteria bind to different regions of the fibronectin molecule. To associate this binding to O157:H7 strains and not just to a specific isolate, the binding of clinical EHEC O157:H7 strains to ECM proteins was tested. No differences in binding to fibronectin, laminin, and collagen IV was observed between the clinical and the prototype strains (Fig. 1E) . Further, the deglycosylation of ECM resulted in a significant reduction in EHEC EDL933 binding to fibronectin and type IV collagen but not to laminin (Fig. 1F) . ECM proteins are glycoproteins that contain 4 to 15% carbohydrate, and glycosylation is either N linked or O linked. While it stabilizes ECM proteins against hydrolysis, glycosylation also may make ECM proteins more vulnerable to fimbria-mediated bacterial binding (8, 27) . Our data implicate fibronectin and type IV collagen oligosaccharides in EHEC binding.
It has been reported that a fim-invertible element deletion occurred in EHEC strains, resulting in a lack of the expression of type 1 fimbriae (28). However, EHEC O157:H7 contains two nonidentical long polar fimbriae (Lpf) loci that share some homology to type 1 fimbriae (35) , and the ability of EHEC to bind mannose derivates and an effect on fimbrial-mediated adherence have been postulated (34) . We evaluated the role of D-mannose in the adherence of EHEC to ECM proteins, and our data indicated that mannose decreases the binding of EHEC to all ECM proteins.
The inactivation of the lpfA1 gene significantly reduced the binding to all of the ECM proteins tested (Fig. 2A) . Complementation analyses using a plasmid expressing Lpf fimbriae confirmed these observations (Fig. 2B) . Antiserum against rLpfA1 was preincubated with the wild-type EHEC strain EDL933, resulting in a reduction in the binding of this strain to levels similar to those observed with the lpfA1 mutant (Fig.  2C ). In addition, the binding of purified rLpfA protein to ECM proteins was observed (Fig. 3) . Overall, these data support the role of the Lpf major subunit as the EHEC protein participating in binding to ECM proteins.
The binding of EHEC strain EDL933 to ECM proteins is not completely reduced after the inactivation of the lpf1 operon (Fig. 2B) , an observation that suggests the involvement of other adhesion factors that mediate binding to ECM proteins. One candidate is the Lpf2 fimbria, which is widely distributed among EHEC isolates, and it also has been shown to participate in the adherence of EHEC to intestinal cells (31) . The specific contribution of the Lpf2 fimbriae in the adherence to ECM proteins is under investigation. Other EHEC adhesins have been implicated in the binding to ECM proteins, such as the HCP (hemorrhagic coli pili) type 4 pili, the E. coli YcbQ laminin-binding fimbriae (ELF), and the EhaB autotransporter. In the case of the ELF fimbriae and HCP pili, the purified major fimbrial subunits bind to either laminin or to fibronectin and laminin, respectively (26, 39) . However, both ELF and HCP are produced only when EHEC strain EDL933 is grown in minimal casein (Minca) medium and/or in contact with bovine kidney cells and not using LB medium or DMEM, as we have shown with Lpf. Moreover, no binding of ELF and HCP to collagen IV was reported previously. These observations suggest that the binding to ECM proteins cannot be attributed to ELF and/or HCP; however, we cannot rule out that the remaining binding observed in the mutants is a result of these or other unidentified adhesion factors. Similarly, a previous report showed that the EhaB autotransporter also binds to ECM proteins. The overexpression of EhaB protein in E. coli K-12 and EDL933 backgrounds promoted the adhesion to collagen I and laminin (37) . However, the ehaB mutant strain showed no differences in binding to these ECM proteins. Therefore, the elucidation of the conditions that induce EhaB expression in EHEC might help to delineate the role of this autotransporter in adhesion to ECM proteins.
ECM proteins have been proposed to act as bridging molecules between the host and bacteria, with a role in their recognition and the activation of signal transduction pathways that control the later steps of pathogenesis. To assay the relevance of EHEC binding to ECM proteins in a relevant in vitro model, we employed T84 monolayer cells in combination with ECM to determine EHEC adhesion properties. The addition of fibronectin, laminin, or collagen IV to T84 cells augmented the numbers of adherent EHEC bacteria (Fig. 4) . A previous study had demonstrated that enteroaggregative E. coli (EAEC), another diarrheagenic E. coli pathotype, binds to ECM proteins, and that the polarized secretion of fibronectin in T84 cells increased EAEC binding (8) . It will be important to evaluate in future experiments whether other E. coli pathotypes share the ability to bind ECM proteins and establish a link with their pathogenic properties.
Overall, we demonstrated the participation of Lpf in the binding of EHEC O157:H7 to ECM proteins and reported that the presence of these ECM proteins augments EHEC adherence to cultured intestinal cells. Our results suggest that ECM proteins participate in the adherence of EHEC during the colonization of the intestinal tract. 
